The therapies that emerged from IRCM were so promising that the Institute signed an agreement with Sanderling Ventures to create Liphorus Pharmaceuticals in order to develop new technology
The therapies that emerged from IRCM were so promising that the Institute signed an agreement with Sanderling Ventures to create Liphorus Pharmaceuticals in order to develop new technology